Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $42.7 million.

  • UNITED THERAPEUTICS's Change in Accured Expenses fell 5.45% to $31.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year increase of 50.80%. This contributed to the annual value of $42.7 million for FY2024, which is 25.22% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Change in Accured Expenses of $42.7 million as of FY2024, which was down 25.22% from $57.1 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Change in Accured Expenses ranged from a high of $57.1 million in FY2023 and a low of -$12.5 million during FY2021.
  • Its 3-year average for Change in Accured Expenses is $48.1 million, with a median of $44.5 million in 2022.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 132.38% in 2021, then surged by 456.00% in 2022.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Change in Accured Expenses stood at $38.6 million in 2020, then tumbled by 132.38% to -$12.5 million in 2021, then spiked by 456.00% to $44.5 million in 2022, then rose by 28.31% to $57.1 million in 2023, then declined by 25.22% to $42.7 million in 2024.